RMAT

Advertisement

cGxPJobs Banner

Intellia Completes Phase 3 Enrollment for HAE Gene Therapy

September 18, 2025 — Cambridge, Massachusetts Intellia has completed enrollment in the global Phase 3 HAELO trial of lonvoguran...

By cGxPwire Editor
September 19, 2025

Read More

Advertisement

cGxPJobs

Directory